Time-Course Analysis of Protein and Lipid Oxidation in the Brains of Yac128 Huntington's Disease Transgenic Mice

被引:14
|
作者
Brocardo, Patricia S. [1 ,2 ,3 ]
McGinnis, Eric [1 ,2 ]
Christie, Brian R. [1 ,2 ,4 ,5 ,6 ]
Gil-Mohapel, Joana [1 ,2 ]
机构
[1] Univ Victoria, Div Med Sci, Victoria, BC, Canada
[2] Univ Victoria, UBC Isl Med Program, Victoria, BC, Canada
[3] Univ Fed Santa Catarina, Dept Morphol Sci, Florianopolis, SC, Brazil
[4] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Program Neurosci, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
基金
加拿大健康研究院; 加拿大创新基金会; 加拿大自然科学与工程研究理事会;
关键词
AGE-RELATED INCREASE; MOUSE MODEL; COENZYME Q(10); NEUROLOGICAL PHENOTYPE; MUTANT HUNTINGTIN; NEURONAL LOSS; DAMAGE; STRESS; DYSFUNCTION; NEURODEGENERATION;
D O I
10.1089/rej.2015.1736
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Huntington's disease (HD) is caused by an expansion of cytosine-adenine-guanine (CAG) repeats within the coding region of the HD gene, which expresses the protein huntingtin and is characterized by selective degeneration of specific neuronal populations, mainly in the striatum and the cortex. The mechanisms that account for this selective neuronal death are multifaceted, but oxidative stress might play an important role in this process. To determine whether changes in the intracellular redox state will result in oxidative damage to cellular macromolecules with disease progression, we analyzed levels of lipid peroxidation (with the thiobarbituric acid reactive substances [TBARS] assay) and protein carbonyl formation (using the 2,4-dinitrophenylhydrazine reaction) in the cerebellum, cerebral cortex, prefrontal cortex, striatum, and hippocampus of the YAC128 HD mouse model at 3, 6, and 12 months of age. With the exception of a transient increase in protein carbonyl levels in the YAC128 prefrontal cortex at 6 months of age, levels of lipid peroxidation and protein oxidation were not significantly different between YAC128 mice and their age-matched wild-type counterparts in any of the brain regions analyzed up to 12 months of age. However, age-related increases in oxidative stress were observed in various brain regions. These results suggest that lipid and protein oxidative damage is not a major contributor to neurodegeneration in the YAC128 brain up to 12 months of age.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 50 条
  • [1] EVALUATION OF HIPPOCAMPAL NEUROGENESIS IN YAC128 HUNTINGTON'S DISEASE TRANSGENIC MICE
    Gil-Mohapel, J.
    Simpson, J. M.
    Pouladi, M. A.
    Hayden, M.
    Christie, B. R.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [2] Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice
    Gil-Mohapel, Joana M.
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (01) : 77 - 86
  • [3] Neuroinflammation in the YAC128 transgenic mouse model of Huntington's disease
    Connolly, C.
    Thiele, J.
    Beck, J.
    Lefroy, C.
    Hill, A.
    Leavitt, B. R.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S58 - S58
  • [4] EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Miralles, Marta Garcia
    Tan, Liang Juin
    Lim, Madeline
    Geva, Michal
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A92
  • [5] Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
    Nascimento-Castro, Cristine de Paula
    Wink, Ana Claudia
    da Fonseca, Victor Silva
    Bianco, Claudia Daniele
    Winkelmann-Duarte, Elisa C.
    Farina, Marcelo
    Rodrigues, Ana Lucia S.
    Gil-Mohapel, Joana
    de Bem, Andreza Fabro
    Brocardo, Patricia S.
    [J]. NEURAL PLASTICITY, 2018, 2018
  • [6] Evaluation of pridopidine in the transgenic YAC128 mouse model of Huntington disease
    Garcia-Miralles, M.
    Yosuf, N. A. B. M.
    Tan, J. Y.
    Kusko, R.
    Tan, L. J.
    Xu, X.
    Orbach, A.
    Geva, M.
    Hayden, M. R.
    Pouladi, M. A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 219 - 219
  • [7] Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease
    Benn, C. L.
    Slow, E. J.
    Farrell, L. A.
    Graham, R.
    Deng, Y.
    Hayden, M. R.
    Cha, J.-H. J.
    [J]. NEUROSCIENCE, 2007, 147 (02) : 354 - 372
  • [8] Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice
    Bayram-Weston, Zubeyde
    Jones, Lesley
    Dunnett, Stephen B.
    Brooks, Simon P.
    [J]. BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 137 - 147
  • [9] YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease
    Ghilan, Mohamed
    Bostrom, Crystal A.
    Hrycitw, Brett N.
    Simpson, Jessica M.
    Christie, Brian R.
    Gil-Mohapel, Joana
    [J]. BRAIN RESEARCH, 2014, 1581 : 117 - 128
  • [10] BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
    Xie, Yuxiang
    Hayden, Michael R.
    Xu, Baoji
    [J]. JOURNAL OF NEUROSCIENCE, 2010, 30 (44): : 14708 - 14718